Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

2023 ESC Guidelines for the management of cardiomyopathies.

Arbelo E., Protonotarios A., Gimeno JR., Arbustini E., Barriales-Villa R., Basso C., Bezzina CR., Biagini E., Blom NA., de Boer RA., De Winter T., Elliott PM., Flather M., Garcia-Pavia P., Haugaa KH., Ingles J., Jurcut RO., Klaassen S., Limongelli G., Loeys B., Mogensen J., Olivotto I., Pantazis A., Sharma S., Van Tintelen JP., Ware JS., Kaski JP., ESC Scientific Document Group .

More information Original publication

DOI

10.1093/eurheartj/ehad194

Type

Journal article

Publication Date

2023-10-01T00:00:00+00:00

Volume

44

Pages

3503 - 3626

Total pages

123

Keywords

Arrhythmia, Arrhythmogenic right ventricular cardiomyopathy, Cardiomyopathies, Diagnosis, Dilated cardiomyopathy, Genetic counselling, Genetic testing, Genetics, Guidelines, Hypertrophic cardiomyopathy, Implantable cardioverter defibrillator, Management, Multimodality imaging, Non-dilated left ventricular cardiomyopathy, Pregnancy, Restrictive cardiomyopathy, Risk stratification, Screening, Sports, Sudden cardiac death, Humans, Cardiomyopathies, Death, Sudden, Cardiac, Arrhythmogenic Right Ventricular Dysplasia, Defibrillators, Implantable